This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1997:220:131-42.

doi: 10.1007/978-3-642-60479-9_8.

TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation

D Ron¹

Affiliations

PMID: 9103679
DOI: 10.1007/978-3-642-60479-9_8

Review

TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation

D Ron. Curr Top Microbiol Immunol. 1997.

. 1997:220:131-42.

doi: 10.1007/978-3-642-60479-9_8.

Author

D Ron¹

Affiliation

¹ Skirball Institute of Biomolecular Medicine, Department of Medicine, New York, NY, USA.

PMID: 9103679
DOI: 10.1007/978-3-642-60479-9_8

No abstract available

PubMed Disclaimer

Similar articles

A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP.
Zinszner H, Albalat R, Ron D. Zinszner H, et al. Genes Dev. 1994 Nov 1;8(21):2513-26. doi: 10.1101/gad.8.21.2513. Genes Dev. 1994. PMID: 7958914
Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.
Hisaoka M, Tsuji S, Morimitsu Y, Hashimoto H, Shimajiri S, Komiya S, Ushijima M. Hisaoka M, et al. Diagn Mol Pathol. 1998 Apr;7(2):96-101. doi: 10.1097/00019606-199804000-00006. Diagn Mol Pathol. 1998. PMID: 9785008
Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.
Kanoe H, Nakayama T, Hosaka T, Murakami H, Yamamoto H, Nakashima Y, Tsuboyama T, Nakamura T, Ron D, Sasaki MS, Toguchida J. Kanoe H, et al. Oncogene. 1999 Jan 21;18(3):721-9. doi: 10.1038/sj.onc.1202364. Oncogene. 1999. PMID: 9989822
Chromosome translocation-mediated conversion of a tumor suppressor gene into a dominant oncogene: fusion of EWS1 to WT1 in desmoplastic small round cell tumors.
Rauscher FJ 3rd. Rauscher FJ 3rd. Curr Top Microbiol Immunol. 1997;220:151-62. doi: 10.1007/978-3-642-60479-9_10. Curr Top Microbiol Immunol. 1997. PMID: 9103681 Review. No abstract available.
Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor.
May WA, Denny CT. May WA, et al. Curr Top Microbiol Immunol. 1997;220:143-50. Curr Top Microbiol Immunol. 1997. PMID: 9103680 Review. No abstract available.

See all similar articles

Cited by

The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.
Engström K, Willén H, Kåbjörn-Gustafsson C, Andersson C, Olsson M, Göransson M, Järnum S, Olofsson A, Warnhammar E, Aman P. Engström K, et al. Am J Pathol. 2006 May;168(5):1642-53. doi: 10.2353/ajpath.2006.050872. Am J Pathol. 2006. PMID: 16651630 Free PMC article.
hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis.
Iervolino A, Santilli G, Trotta R, Guerzoni C, Cesi V, Bergamaschi A, Gambacorti-Passerini C, Calabretta B, Perrotti D. Iervolino A, et al. Mol Cell Biol. 2002 Apr;22(7):2255-66. doi: 10.1128/MCB.22.7.2255-2266.2002. Mol Cell Biol. 2002. PMID: 11884611 Free PMC article.
The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma.
Zullow HJ, Sankar A, Ingram DR, Samé Guerra DD, D'Avino AR, Collings CK, Lazcano R, Wang WL, Liang Y, Qi J, Lazar AJ, Kadoch C. Zullow HJ, et al. Mol Cell. 2022 May 5;82(9):1737-1750.e8. doi: 10.1016/j.molcel.2022.03.019. Epub 2022 Apr 6. Mol Cell. 2022. PMID: 35390276 Free PMC article.
A novel type of EWS-CHOP fusion gene in two cases of myxoid liposarcoma.
Hosaka T, Nakashima Y, Kusuzaki K, Murata H, Nakayama T, Nakamata T, Aoyama T, Okamoto T, Nishijo K, Araki N, Tsuboyama T, Nakamura T, Toguchida J. Hosaka T, et al. J Mol Diagn. 2002 Aug;4(3):164-71. doi: 10.1016/S1525-1578(10)60698-8. J Mol Diagn. 2002. PMID: 12169678 Free PMC article.
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis.
Perrotti D, Bonatti S, Trotta R, Martinez R, Skorski T, Salomoni P, Grassilli E, Lozzo RV, Cooper DR, Calabretta B. Perrotti D, et al. EMBO J. 1998 Aug 3;17(15):4442-55. doi: 10.1093/emboj/17.15.4442. EMBO J. 1998. PMID: 9687511 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

CA60945/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Springer
Research Materials
- NCI CPTC Antibody Characterization Program